MBOAT7 and COVID-19: To explore changes in MBOAT7 expression in COVID-19, we analyzed a single-cell RNA sequencing (scRNA-seq) dataset of 284 samples from 196 COVID-19 patients; 249 were PBMC samples, each with >1,000 single cells available for the expression levels of MBOAT7 in broad categories of immune cells including neutrophils, macrophages, plasma B cells, T cells, and NK cells53.